Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Status:
Completed
Trial end date:
2013-01-08
Target enrollment:
Participant gender:
Summary
RATIONALE: Armodafinil may help relieve fatigue and improve quality of life in patients with
cancer receiving radiation therapy to the brain.
PURPOSE: This clinical trial is studying how well armodafinil works in treating fatigue
caused by radiation therapy in patients with primary brain tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Cancer Center CCOP Research Base Wake Forest University Health Sciences